Reumatología Expresión del ligando del receptor activador Nf-kB (Rankl) en los fibroblastos de la membrana sinovial de pacientes con artritis reumatoide
Bibliografía
Firestein G.S. Etiology and Pathogenesis of rheumatoid arthritis. In: Textbook of Rheumatology. Sixth Edition, Editado por S. Ruddy, E. Harris, C. Sledge. Philadelphia, W.B. Saunders Company, 2001.
Suzuki Y., Tsutsumi Y., Nakagawa M., Suzuki H., Matsushita K., Beppu M., et al. Osteoclast-like cells in a in vitro model of bone destruction by rheumatoid synovium. Rheumatology 2001; 40:673-682.
Franz J.K., Pap T., Muller-Ladner U., Gay R.E., Burmester G.R.,Gay S. T-cell independent joint destruction. In: T cell in arthritis. Editado por P Miossec, GS Firestein. Birkenhauser, 1998.
Fassbender H.G. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 1983; 3:141-155.
Lafyatis R., Remmers E.F., Roberts A.B., Yocum D.E., Sporn M.B., Wilder R.L. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989; 83:1267-1276.
Takayanagi H., Lizuka H., Jujuy T., Nakagawa T., Yamamoto A., Miyazaki T., et al. Involvement of receptor activator of nuclear factor kB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43:259-269.
Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999; 402:304-309.
Shigeyama Y., Pap T., Kunzler P., Simmen B.R., Gay R.E., Gay S., et al. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 2000; 43:2523-2530.
Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang MS., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89:309-319.
Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S.I., et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 139:1329-1337.
Yamaguchi B., Kinosaki M., Goto K., Kobayashi F., Tsuda E., Mochizuki S.,et al. Characterization of structural domain of human osteoclastogenesis inhibitort factor. J Biol. Chem 1998; 273:5117-5123.
Lacey D.L., Timms E., Tan H.L., Kelley L., Dunstan M.J., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-176.
Gravallese E.M., Manning C., Tsay A., Naito A., Pan C., Amento E., et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43:250-258.
Horwood N.J., Kartsogiannis V., Quinn J.M.W., Romas E., Martin T.J., Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Común 1999; 265:144-150.
Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki SI., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95:3597-3602.
Itonaga I., Fujikawa Y., Sabokbar A., Murray D.W., Athanasou N.A. Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent. J Pathol 2000; 192:97-104.
Romas E., Bakharevski O., Hards D.K., Kartsogiannis V., Quinn J.M., Ryan P.F., et al. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 2000; 43:821-826.
Haynes D.R., Crotti T.N., Loric M., Bain G.I., Atkins G.J., Findlay D.M. Osteoprotegerin and receptor activator of nuclear factor kB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology 2001; 40:623-630.
López-Benítez C.M., Placeres F.A., Alonzo E.J., Rodríguez M.A. Papel patogénico de los fibroblastos en la membrana sinovial de pacientes con artritis reumatoide. Revista de la Facultad de Medicina 2001; 24:42-46.
Pap T., Franz J.K., Hummel K.M., Jeisy E., Gay R., Gay S. Activation of synovial fibroblasts in rheumatoid arthritis: lack of expresión of the tumour suppresor PTEN at sites of invasive growth and destruction. Arthritis Res 2000; 2:59-65.
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
